Advances in Therapy

Adis, Springer Healthcare

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Advances in Therapy is a journal published by Adis, Springer Healthcare in United Kingdom. It is listed in MEDLINE according to the sources read. Declared publication charge: 4,390 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Adis, Springer Healthcare
ISSN
0741-238X · 1865-8652
Country
United Kingdom
Access
Not open access / not declared
Declared publication charge
4,390 EUR
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 1990-01-01
Indexing
MEDLINE
APC
4,390 EUR
Declared review time (DOAJ)
—
Actual review time (measured)
74 days received→accepted — computed from PubMed (n=92)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

4665

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

112

i10-index

2439

From OpenAlex open data (CC0).

Editorial & policy6
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
96%
ORCID iDs in current deposits
65%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity3
Alternate titles
Adv Ther.The international journal of drug, device & diagnostic research
Source type
journal
NLM unique ID (PubMed)
8611864
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Health Systems, Economic Evaluations, Quality of Life
  • Diabetes Treatment and Management
  • Diabetes Treatment and Management
  • Diabetes Treatment and Management
  • Asthma and respiratory diseases
  • Diabetes Management and Research
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Blood Pressure and Hypertension Studies
Show all subjects (75)
  • Asthma and respiratory diseases
  • Asthma and respiratory diseases
  • Rheumatoid Arthritis Research and Therapies
  • Rheumatoid Arthritis Research and Therapies
  • Rheumatoid Arthritis Research and Therapies
  • Diabetes Management and Research
  • Diabetes Management and Research
  • Glaucoma and retinal disorders
  • Glaucoma and retinal disorders
  • Retinal Diseases and Treatments
  • Glaucoma and retinal disorders
  • Retinal Diseases and Treatments
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Biosimilars and Bioanalytical Methods
  • Blood Pressure and Hypertension Studies
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Blood Pressure and Hypertension Studies
  • Biosimilars and Bioanalytical Methods
  • Biosimilars and Bioanalytical Methods
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Inflammatory Bowel Disease
  • Dermatology and Skin Diseases
  • Psoriasis: Treatment and Pathogenesis
  • Psoriasis: Treatment and Pathogenesis
  • Medication Adherence and Compliance
  • Inhalation and Respiratory Drug Delivery
  • Spondyloarthritis Studies and Treatments
  • Spondyloarthritis Studies and Treatments
  • Drug-Induced Ocular Toxicity
  • Psoriasis: Treatment and Pathogenesis
  • Medication Adherence and Compliance
  • Medication Adherence and Compliance
  • Ocular Surface and Contact Lens
  • Ocular Surface and Contact Lens
  • Inflammatory Bowel Disease
  • Inflammatory Bowel Disease
  • Pharmacology and Obesity Treatment
  • Venous Thromboembolism Diagnosis and Management
  • Atrial Fibrillation Management and Outcomes
  • Atrial Fibrillation Management and Outcomes
  • Lung Cancer Treatments and Mutations
  • Dermatology and Skin Diseases
  • Lipoproteins and Cardiovascular Health
  • Pharmaceutical studies and practices
  • Lung Cancer Treatments and Mutations
  • Dermatology and Skin Diseases
  • Lipoproteins and Cardiovascular Health
  • Lipoproteins and Cardiovascular Health
  • Economic and Financial Impacts of Cancer
  • Heart Failure Treatment and Management
  • Anesthesia and Pain Management
  • Inhalation and Respiratory Drug Delivery
  • Heart Failure Treatment and Management
  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Inhalation and Respiratory Drug Delivery
  • Pain Management and Opioid Use
  • Pharmacogenetics and Drug Metabolism
  • Chronic Kidney Disease and Diabetes
  • Respiratory and Cough-Related Research
  • Respiratory and Cough-Related Research
  • Bariatric Surgery and Outcomes
  • Corneal surgery and disorders
  • Bariatric Surgery and Outcomes
  • Corneal surgery and disorders

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: